Alpha Teknova (TKNO) Expected to Announce Earnings on Thursday

Alpha Teknova (NASDAQ:TKNO) is expected to be posting its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect Alpha Teknova to post earnings of ($0.09) per share and revenue of $9.6190 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:30 PM ET.

Alpha Teknova Trading Up 2.0%

Alpha Teknova stock opened at $2.03 on Thursday. The firm has a market cap of $108.66 million, a PE ratio of -5.80 and a beta of 0.41. Alpha Teknova has a 12 month low of $1.91 and a 12 month high of $8.45. The stock’s 50 day simple moving average is $3.44 and its two-hundred day simple moving average is $4.35. The company has a current ratio of 5.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.18.

Hedge Funds Weigh In On Alpha Teknova

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Susquehanna International Group LLP increased its stake in shares of Alpha Teknova by 25.0% during the third quarter. Susquehanna International Group LLP now owns 16,206 shares of the company’s stock worth $100,000 after purchasing an additional 3,246 shares in the last quarter. Larson Financial Group LLC boosted its holdings in Alpha Teknova by 58.5% in the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock worth $58,000 after buying an additional 3,464 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Alpha Teknova by 123.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after buying an additional 4,504 shares in the last quarter. Bridgeway Capital Management LLC raised its holdings in shares of Alpha Teknova by 7.9% during the third quarter. Bridgeway Capital Management LLC now owns 80,900 shares of the company’s stock valued at $501,000 after acquiring an additional 5,900 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Alpha Teknova in the second quarter valued at approximately $29,000. 13.81% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a report on Wednesday, January 21st. Zacks Research raised shares of Alpha Teknova to a “hold” rating in a research note on Wednesday, December 10th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $8.00.

Alpha Teknova Company Profile

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.